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EditorialSeeking Questions Over AnswersHallowed conventions support rich meaningful discourse. In
popular journalism, the editorial article, for instance, convention-
ally must provide a ‘‘bottom line’’ that catalyzes discussion and
debate. In research, top studies in the life sciences are justly
prized for what they provide in terms of biological insight, molec-
ular mechanism, and conceptual novelty. But when is it time to
develop new conventions to foster new modes of discourse?
This month, inspired by this issue’s articles and the inaugural
Solve conference (solve.mit.edu), we break with convention
and pose problems rather than solutions centered on three
topics that have been top of mind. We hope this shift will ulti-
mately lead our readers to articulate new questions and identify
unforeseen solutions.
Humans, the New ‘‘Model Organism’’
Three articles in this issue showcase that humans could be the
major experimental organism in biological research. Many within
the research community recognize the promise of population
studies on exceptionally large cohorts of people, with the aim
of better understanding the human body in health and disease.
This approach is exemplified by Michael Inouye and colleagues
(pp. 293–301), who use multi-omic data and health records
from >10,000 individuals to elucidate the biological processes
underlying a blood biomarker called GlycA.
In addition, Atul Butte reminds us that we need to think beyond
molecular-level data and consider the effects of behavior, the
environment, and other non-genomic factors on human physi-
ology and disease (Q&A, pp. 254–255). This broader view pro-
vides the context that’s necessary if we are to understand which
parts of biology are medically important. This, in turn, may pro-
vide the personalized medicine of the future. For example,
Neema Jamshidi and colleagues use a metabolic model that is
‘‘personalized’’ based on data from metabolite profiling of hu-
man blood samples to predict mechanisms underlying drug re-
sponses (pp. 283–292).
Together, these articles highlight the tremendous promise of
high-resolution, multi-dimensional profiling of human physiology
and the aggregation of these data across many individuals to
enable the regular study of human biology directly.
What advances would help realize the promise of large human
cohorts for research?
The Enduring Value of Curated Insights
Data and analytics, it’s been said, are the new game in town. For
instance, with the ever-growing capabilities of technologies to
measure the previously unmeasurable and to monitor healthcontinuously over time, it is tempting to believe that machines
will solve medicine’s problems by crunching these data.
Yet it is impossible to ignore our collective appetite for human-
curated insight that we can trust. Human curation is powering
new music discovery features on streaming music platforms.
Curated email newsletters are all the rage (https://tinyletter.
com/edyong209, http://ben-evans.com/#newsletter, http://
www.lennyletter.com/). Moreover, in systems biology, we also
know that measurements alone are not enough. Without knowl-
edge and insight, vast amounts of data may result in ‘‘garbage-
in-garbage-out’’ writ large.
What strategies and tools best allow the strengths of human
insight to be effectively augmented using data, computation,
theory, and quantitative measurement?
Practical Solutions Deployed for Large Impact
This month we had the privilege of attending the inaugural Solve
conference (solve.mit.edu). Although bold, inspiring new ideas
were in abundance, a theme evident across the four pillars of
the conference (Cure, Fuel, Make, and Learn) was the challenge
of making the best use of what we already have. For example,
Anthony Fauci, head of the National Institute of Allergy and Infec-
tious Diseases, noted that many infectious diseases can be
controlled, and so solving challenges related to the implementa-
tion and delivery of these control measures, especially in devel-
oping countries, is worth elevating side-by-side with new tech-
nological solutions such as an HIV vaccine.
A major challenge here is cultural. The solutions to implemen-
tation problems are often modest and appear obvious in retro-
spect. This make them easy to overlook, despite the insight
and creativity they require and their clear real-world impact.
What implementation challenges, if overcome, would enable
the greatest progress in the life sciences? What can be done
so that implementation and delivery research receives greater
recognition?
#SeekQuestions
Thesequestions represent asamplingofwhatwe’vebeen thinking
about this month. What questions are you pursuing or wish were
pursued more vigorously? Continue the dialog with @CellSys-
temsCP on Twitter #SeekQuestions, comment at the online
version of this article, or email us at systems@cell.com. We hope
to share select responses in future issues of Cell Systems.—The Cell Systems editorial team
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